Interpreting clinically significant changes in patient-reported outcomes

Cancer

Volumn 110, Issue 1, 2007, Pages 196-202

  Ringash, Jolie ^a,c   O'Sullivan, Brian ^a   Bezjak, Andrea ^a   Redelmeier, Donald A ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Head and neck neoplasms; Health utility; Laryngeal neoplasms; Meaningful change; Minimal important difference; Outcomes; Patient reported outcomes; Quality of life; Questionnaires

Indexed keywords

ARTICLE; DAILY ACTIVE TIME EXCHANGE; FUNCTIONAL ASSESSMENT; FUNCTIONAL ASSESSMENT OF CANCER THERAPY GENERAL SCALE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY HEAD AND NECK SCALE; HUMAN; LARYNX CANCER; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SELF REPORT;

CARCINOMA, SQUAMOUS CELL; GROUP PROCESSES; HEALTH STATUS; HUMANS; LARYNGEAL NEOPLASMS; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; QUESTIONNAIRES; SELF CONCEPT;

EID: 34250801499     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22799     Document Type: Article

References (33)

1. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol. 2003;56:395-407.
2. Guyatt GH, Feeny DH, Patrick D. Proceedings of the International Conference on the Measurement of Quality of Life as an Outcome in Clinical Trials: postscript. Control Clin Trials. 1991;12:266S-269S.
3. Wright JG. The minimal important difference: who's to say what is important? J Clin Epidemiol. 1996;49:1221-1222.
4. Jaeschke R, Singer J, Guyatt GH. Measurement of health status: Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10:407-415.
5. Ringash J, Redelmeier DA, O'Sullivan B, Bezjak A. Quality of life and utility in irradiated laryngeal cancer patients. Int J Radiat Oncol Biol Phys. 2000;47:875-881.
6. Sobin LH, Wittekind Ch. International Union Against Cancer TNM Classification of Malignant Tumours. 5th ed. New York: John Wiley; 1997:33-37.
7. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM, ed. Evaluation of Chemotherapeutic Agents. New York: Columbia University Press; 1949:191-205.
8. Cella DF. Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Scales. Evanston, Ill: Center on Outcomes, Research and Education (CORE), Northwestern Healthcare and Northwestern University; 1997.
9. Pliskin JS, Shepard DS, Weinstein MD. Utility function for life years and health status. Oper Res. 1980;28:206-224.
10. Wolfson A, Sinclair A, Bombardier C. Preference measures for functional status in stroke patients. Interrater and intertechnique comparisons. In Kane RL, Dane RA, eds. Values and Long-term Care. Lexington Mass: Lexington Books; 1982:191-212.
11. Read JL, Quinn RJ, Berwick DM, Fineberg HV, Weinstein MC. Preferences for health outcomes: comparison of assessment method. Med Decis Making. 1984;4:315-329.
12. Ringash J. Quality of life in laryngeal cancer patients [dissertation]. Toronto, ON: University of Toronto; 1999.
13. Buckingham JK, Birdsall J, Douglas JG. Comparing three versions of the time tradeoff: time for a change? Med Decis Making. 1996;16:335-347.
14. Redelmeier DA, Guyatt GH, Goldstein RS. Assessing the minimal important difference in symptoms: a comparison of two techniques. J Clin Epidemiol. 1996;49:1215-1219.
15. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol. 1994;47:81-87.
16. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139-144.
17. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt G. Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med. 1997;155:1278-1282.
18. Redelmeier DA, Lorig K. Assessing the clinical importance of symptomatic improvements. An illustration in rheumatology. Arch Intern Med. 1993;153:1337-1342.
19. Wells GA, Tugwell P, Kraag GR, Baker PR, Groh J, Redelmeier DA. Minimum important difference between patients with rheumatoid arthritis: the patient's perspective. J Rheumatol. 1993;20:557-560.
20. Redelmeier DA, Goldstein RS, Min ST, Hyland RH. Spirometry and dyspnea in patients with COPD. When small differences mean little. Chest. 1996;109:1163-1168.
21. Moses LE. Think and explain with statistics. Reading, Mass: Addison Wesley; 1986:336-338.
22. Cella D, Hahn EA, Dineen K. Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening. Qual Life Res. 2002;11:207-221.
23. Eton DT, Cella D, Yost KJ, et al. A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol. 2004;57:898-910.
24. Cella D, Eton DT, Fairclough DL, et al. What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from the Eastern Cooperative Oncology Group (ECOG) Study 5592. J Clin Epidemiol. 2002;55:285-295.
25. Barrett B, Brown D, Mundt M, Brown R. Sufficiently important difference: expanding the framework of clinical significance. Med Decision Making. 2005;25:250-261.
26. Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14:1523-1532.
27. Weinstein ND. Optimistic biases about personal risks. Science. 1989;246:1232-1233.
28. Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York, Academic Press, 1969.
29. Sloan JA, Cella D, Hays RD. Clinical significance of patient-reported questionnaire data: Another step toward consensus. J Clin Epidemiol. 2005;58:1217-1219.
30. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41:582-592.
31. Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol. 1999;52:861-873.
32. Torrance GW Social preferences for health states: an empirical evaluation of three measurement techniques. SocioEcon Plan Sci. 1976;10:129-136.
33. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol. 1984;2:187-193.